FinalDose
PrivateLast Round
Accelerator
Mar 1, 2026
Est. Valuation
$1.79M
Total Funding Raised
$5.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
FinalDose is a biotechnology company developing a programmable drug platform that uses DNA recognition to find and destroy diseased cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FinalDose Comparables
Compare FinalDose with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoSenX | 78% | |
| SynsoryBio | 77% | |
| Granza Bio | 71% |
FinalDose Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 1, 2026 |
FinalDose Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Y Combinator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 2, 2026
Grew 120% QoQ, from 5 to 11 employees.
- Jul 21, 2026
Grew 80% QoQ from 5 to 9 employees.
FinalDose Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about FinalDose's valuation, stock price, and market status.
Is FinalDose a public or private company?
FinalDose is a private company.
What is the current stock price of FinalDose?
FinalDose is a private company with no public stock price. No recent secondary market data is available.
How much is FinalDose worth (valuation)?
FinalDose's valuation is estimated at $1.8M based on funding round data.
Can I buy FinalDose stock?
FinalDose shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was FinalDose's last funding round?
FinalDose's most recent funding round was Accelerator on March 1, 2026.
Who are the main investors in FinalDose?
Key investors in FinalDose include Y Combinator.
Will FinalDose IPO soon?
No public IPO plans have been announced for FinalDose.
How can I track FinalDose secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor FinalDose's secondary market activity and sign up for updates.